Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)
Clinical trial NCT00503750 · COMPLETED
Trial details
- NCT number
- NCT00503750
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2011-07-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.